Day Zero Diagnostics epiXact WGS Sequencing Service

Day Zero Diagnostics (DZD) has commercially launched its epiXact whole genome sequencing and analysis service for hospital-acquired infection outbreak investigations. According to DZD, the service allows hospital infection control teams to determine the relationships between infections during a suspected outbreak. The firm said that the service can provide results in two to three days and can help hospital confidently and quickly decide how to perform interventions for patient safety.